Globus Medical Return on Tangible Equity 2010-2025 | GMED
Current and historical return on tangible equity values for Globus Medical (GMED) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Globus Medical Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-06-30 | $0.36B | $2.06B | 18.56% |
| 2025-03-31 | $0.19B | $1.88B | 10.21% |
| 2024-12-31 | $0.10B | $1.95B | 5.96% |
| 2024-09-30 | $0.09B | $1.80B | 5.51% |
| 2024-06-30 | $0.04B | $1.66B | 2.45% |
| 2024-03-31 | $0.07B | $1.58B | 3.97% |
| 2023-12-31 | $0.12B | $1.64B | 7.20% |
| 2023-09-30 | $0.16B | $1.80B | 9.33% |
| 2023-06-30 | $0.20B | $1.73B | 12.55% |
| 2023-03-31 | $0.20B | $1.66B | 12.91% |
| 2022-12-31 | $0.19B | $1.59B | 12.43% |
| 2022-09-30 | $0.16B | $1.53B | 10.30% |
| 2022-06-30 | $0.16B | $1.46B | 10.38% |
| 2022-03-31 | $0.14B | $1.54B | 9.59% |
| 2021-12-31 | $0.15B | $1.49B | 10.45% |
| 2021-09-30 | $0.19B | $1.48B | 13.66% |
| 2021-06-30 | $0.18B | $1.41B | 14.15% |
| 2021-03-31 | $0.12B | $1.33B | 9.84% |
| 2020-12-31 | $0.10B | $1.26B | 8.61% |
| 2020-09-30 | $0.10B | $1.21B | 8.14% |
| 2020-06-30 | $0.09B | $1.12B | 7.75% |
| 2020-03-31 | $0.15B | $1.15B | 13.04% |
| 2019-12-31 | $0.16B | $1.20B | 14.01% |
| 2019-09-30 | $0.15B | $1.13B | 13.89% |
| 2019-06-30 | $0.14B | $1.07B | 14.29% |
| 2019-03-31 | $0.15B | $1.03B | 15.67% |
| 2018-12-31 | $0.16B | $0.97B | 17.33% |
| 2018-09-30 | $0.14B | $0.93B | 16.87% |
| 2018-06-30 | $0.14B | $0.90B | 16.80% |
| 2018-03-31 | $0.12B | $0.82B | 15.77% |
| 2017-12-31 | $0.11B | $0.77B | 14.92% |
| 2017-09-30 | $0.11B | $0.73B | 15.46% |
| 2017-06-30 | $0.11B | $0.70B | 16.01% |
| 2017-03-31 | $0.11B | $0.70B | 15.84% |
| 2016-12-31 | $0.10B | $0.66B | 16.16% |
| 2016-09-30 | $0.12B | $0.63B | 18.87% |
| 2016-06-30 | $0.12B | $0.66B | 19.53% |
| 2016-03-31 | $0.12B | $0.62B | 20.37% |
| 2015-12-31 | $0.11B | $0.59B | 21.12% |
| 2015-09-30 | $0.10B | $0.55B | 20.12% |
| 2015-06-30 | $0.10B | $0.52B | 19.94% |
| 2015-03-31 | $0.10B | $0.49B | 19.69% |
| 2014-12-31 | $0.09B | $0.50B | 19.19% |
| 2014-09-30 | $0.09B | $0.51B | 18.45% |
| 2014-06-30 | $0.08B | $0.48B | 18.62% |
| 2014-03-31 | $0.07B | $0.45B | 16.24% |
| 2013-12-31 | $0.07B | $0.42B | 16.71% |
| 2013-09-30 | $0.07B | $0.42B | 17.37% |
| 2013-06-30 | $0.06B | $0.40B | 17.29% |
| 2013-03-31 | $0.08B | $0.38B | 21.89% |
| 2012-12-31 | $0.07B | $0.36B | 22.95% |
| 2012-09-30 | $0.07B | $0.34B | 22.46% |
| 2012-06-30 | $0.07B | $0.31B | 31.85% |
| 2012-03-31 | $0.06B | $0.28B | 45.17% |
| 2011-12-31 | $0.06B | $0.27B | 84.53% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.275B | $2.519B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $186.057B | 22.51 |
| Intuitive Surgical (ISRG) | United States | $169.665B | 70.33 |
| IDEXX Laboratories (IDXX) | United States | $51.770B | 53.88 |
| Edwards Lifesciences (EW) | United States | $47.755B | 31.65 |
| Alcon (ALC) | Switzerland | $39.366B | 26.43 |
| IQVIA Holdings (IQV) | United States | $32.438B | 18.33 |
| DexCom (DXCM) | United States | $29.545B | 44.32 |
| Mettler-Toledo (MTD) | United States | $26.800B | 31.81 |
| STERIS (STE) | Ireland | $24.136B | 25.69 |
| Waters (WAT) | United States | $17.964B | 24.68 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.399B | 0.00 |
| Hologic (HOLX) | United States | $14.929B | 16.17 |
| Penumbra (PEN) | United States | $10.633B | 77.68 |
| Sysmex ADR (SSMXY) | Japan | $7.913B | 25.14 |
| Masimo (MASI) | United States | $7.590B | 25.54 |
| Teleflex (TFX) | United States | $5.586B | 9.02 |
| Glaukos (GKOS) | United States | $5.495B | 0.00 |
| TransMedics (TMDX) | United States | $3.919B | 59.56 |
| Integer Holdings (ITGR) | United States | $3.779B | 18.86 |
| LivaNova (LIVN) | United Kingdom | $3.078B | 17.62 |
| Veracyte (VCYT) | United States | $2.387B | 32.98 |
| Alphatec Holdings (ATEC) | United States | $2.353B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.235B | 0.00 |
| Artivion (AORT) | United States | $2.073B | 104.60 |
| Nihon Kohden (NHNKY) | Japan | $1.992B | 23.78 |
| Elekta AB (EKTAY) | Sweden | $1.815B | 17.59 |
| Integra LifeSciences Holdings (IART) | United States | $1.179B | 6.75 |
| OPKO Health (OPK) | United States | $1.095B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.046B | 0.00 |
| IRadimed (IRMD) | United States | $0.921B | 44.72 |
| Tandem Diabetes Care (TNDM) | United States | $0.845B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.819B | 0.00 |
| AxoGen (AXGN) | United States | $0.743B | 0.00 |
| SiBone (SIBN) | United States | $0.719B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.592B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.554B | 9.79 |
| OrthoPediatrics (KIDS) | United States | $0.536B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.464B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.439B | 3.52 |
| AngioDynamics (ANGO) | United States | $0.417B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.393B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.385B | 91.83 |
| Mesa Laboratories (MLAB) | United States | $0.373B | 9.48 |
| RxSight (RXST) | United States | $0.370B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.309B | 0.00 |
| NeuroPace (NPCE) | United States | $0.303B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.298B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.297B | 20.48 |
| Alpha Tau Medical (DRTS) | Israel | $0.290B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.236B | 0.00 |
| 908 Devices (MASS) | United States | $0.224B | 0.00 |
| Neuronetics (STIM) | United States | $0.220B | 0.00 |
| Inogen (INGN) | United States | $0.216B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.213B | 0.00 |
| CVRx (CVRX) | United States | $0.205B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.174B | 0.00 |
| Accuray (ARAY) | United States | $0.171B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.150B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.137B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.107B | 0.00 |
| InspireMD (NSPR) | United States | $0.102B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.099B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.088B | 0.00 | |
| EDAP TMS S.A (EDAP) | France | $0.085B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.015B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.60 |